Table of Contents
PharmSights
Cyclosporin A Enhances Cell Survival in Neural Precursor Populations in the Adult Central Nervous System |
Abstract PDF |
Jessica Hunt, Cindi Morshead |
81-88 |
DP2 Receptor Antagonists: Novel Therapeutic Target for COPD |
Abstract PDF |
Karin J. Stebbins, Jilly F. Evans, Daniel S. Lorrain |
89-96 |
Implications of a Newly Discovered DR5 Specific Antagonistic Peptide for Neurodegenerative Disorders |
Abstract PDF |
Mariette S. Heins, Wim J. Quax |
97-100 |
Research Articles
Mitochondrial and Plasma Membrane Citrate Transporters: Discovery of Selective Inhibitors and Application to Structure/Function Analysis |
Abstract PDF |
Jiakang Sun, Sreevidya Aluvila, Rusudan Kotaria, June A. Mayor, D. Eric Walters, Ronald S. Kaplan |
101-110 |
Reviews
G Protein-Coupled Receptor 87: a Promising Opportunity for Cancer Drug Discovery |
Abstract PDF |
Yanhong Zhang, Ariane Scoumanne, Xinbin Chen |
111-116 |
The “Two faces” of Tumor Suppressor p53-revisited |
Abstract PDF |
Martin L. Smith, M.A. Suresh Kumar |
117-119 |
FDA Corner
FDA Approves New Injectable Osteoporosis Treatment for Postmenopausal Women |
Abstract PDF |
|
121 |
FDA Approves New Treatment for Late-Onset Pompe Disease |
Abstract PDF |
|
121-122 |
FDA Approves New Combination Product Oral Contraceptive |
Abstract PDF |
|
122 |
FDA Approves a Cellular Immunotherapy for Men with Advanced Prostate Cancer |
Abstract PDF |
|
122-123 |
LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041
Copyright © 2008 LumiText Publishing. All rights reserved.